AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY, as the first and only T-cell engaging bispecific antibody for the...
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Polivy in combination with Rituxan, cyclophosphamide,...
